文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

间充质干细胞/基质细胞在多微生物脓毒症动物模型中增加心脏miR-187-3p表达

Mesenchymal Stem/Stromal Cells Increase Cardiac miR-187-3p Expression in a Polymicrobial Animal Model of Sepsis.
PubMed 文献 · Shock · 2021-01-01
一句话结论小鼠CLP脓毒症模型中,MSC治疗上调心脏miR-187等5个miRNA、下调3个枢纽基因,减轻炎症与凋亡通路。

本研究为动物实验,将小鼠随机分为盲肠结扎穿刺(CLP)脓毒症组或假手术组,分别给予MSC(2.5×10^5)或生理盐水安慰剂。结果显示MSC治疗上调包括miR-187在内的5个miRNA,下调Itpkc、Lrrc59、Tbl1xr1三个枢纽基因,并降低炎症与凋亡通路、增加心肌特异性结构与功能基因表达。提示MSC可能通过调控宿主miRNA保护心肌细胞免受脓毒症诱导的心肌功能障碍。

要点

  • MSC治疗上调5个miRNA(包括miR-187),下调3个枢纽基因Itpkc、Lrrc59、Tbl1xr1。
  • MSC治疗降低心脏炎症与凋亡通路表达,增加心肌特异性结构与功能基因表达。
  • 该研究为动物模型机制探索,尚未提供临床患者中的剂量、疗效或安全性数据。

适用人群与场景

  • 实验为小鼠多微生物脓毒症模型(盲肠结扎穿刺CLP)或假手术对照,非临床患者人群。

诊断标准与关键阈值

  • 动物模型采用CLP诱导多微生物脓毒症,假手术为对照。

处置流程与药物剂量

  • 原文未提及临床给药途径、频次、疗程或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为动物实验,小鼠随机分为CLP脓毒症或假手术,分别给予MSC(2.5×10^5)或生理盐水。
  • 网络分析与RT-qPCR显示MSC治疗上调5个miRNA(包括miR-187),下调3个枢纽基因Itpkc、Lrrc59、Tbl1xr1。
  • 功能上MSC治疗降低炎症与凋亡通路,增加心肌特异性结构与功能基因表达。

证据类型、等级与局限

  • 证据类型为动物实验(小鼠CLP脓毒症模型),非临床RCT或队列研究。
  • 局限:动物模型结果需进一步临床验证;原文未提及样本量、盲法或单中心等设计细节。

对床旁实践的改变

  • 该内容为动物机制研究,尚不能改变急诊/ICU对脓毒症心肌功能障碍的临床处置。
  • 不适用于临床患者决策;MSC的临床剂量、途径、疗程及获益风险均未在原文中提供。
  • 常见陷阱:将动物模型中2.5×10^5的MSC剂量或miR-187变化误读为临床推荐或监测指标。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Sepsis-induced myocardial dysfunction (MD) is an important pathophysiological feature of multiorgan failure caused by a dysregulated host response to infection. Patients with MD continue to be managed in intensive care units with limited understanding of the molecular mechanisms controlling disease pathogenesis. Emerging evidences support the use of mesenchymal stem/stromal cell (MSC) therapy for treating critically ill septic patients. Combining this with the known role that microRNAs (miRNAs) play in reversing sepsis-induced myocardial-dysfunction, this study sought to investigate how MSC administration alters miRNA expression in the heart. Mice were randomized to experimental polymicrobial sepsis induced by cecal ligation and puncture (CLP) or sham surgery, treated with either MSCs (2.5 × 105) or placebo (saline). Twenty-eight hours post-intervention, RNA was collected from whole hearts for transcriptomic and microRNA profiling. The top microRNAs differentially regulated in hearts by CLP and MSC administration were used to generate a putative mRNA-miRNA interaction network. Key genes, termed hub genes, within the network were then identified and further validated in vivo. Network analysis and RT-qPCR revealed that septic hearts treated with MSCs resulted in upregulation of five miRNAs, including miR-187, and decrease in three top hit putative hub genes (Itpkc, Lrrc59, and Tbl1xr1). Functionally, MSC administration decreased inflammatory and apoptotic pathways, while increasing cardiac-specific structural and functional, gene expression. Taken together, our data suggest that MSC administration regulates host-derived miRNAs production to protect cardiomyocytes from sepsis-induced MD.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ektesabi AM, Mori K, Tsoporis JN, et al. Mesenchymal Stem/Stromal Cells Increase Cardiac miR-187-3p Expression in a Polymicrobial Animal Model of Sepsis. Shock. 2021. PMID: 33378320. doi:10.1097/SHK.0000000000001701

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。